call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Car T Cell Therapy Market
Inquire Before Buying Request for Sample

Car T Cell Therapy Market

Home Healthcare And Pharmaceutical Car T Cell Therapy Market

CAR-T Cell Therapy Market, By Drug Indication (Axicabtagene Ciloleucel (Yescarta), Brexucabtagene Autoleucel (Tecartus), Ciltacabtagene Autoleucel (Carvykti), Idecabtagene Vicleucel (Abecma), Lisocabtagene Maraleucel (Breyanzi), Tisagenlecleucel (Kymriah), Others); By Indication (Acute Lymphoblastic Leukemia, Non-Hodgkin Lymphoma, Multiple Myeloma); By End User (Hospitals, Oncology Treatment Centers); By Region (North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA)), Global Trend Analysis, Competitive Landscape & Forecast, 2019–2030

  • Published Date: October 2024
  • Report ID: BWC24781
  • Available Format: PDF
  • Page: 418

Report Overview

An increasing number of cancer incidents, a spurring demand for targeted and personalized therapies, adoption of advancements in CAR-T technology, and growing number of clinical trial programs are expected to drive Global CAR-T Cell Therapy Market during the forecast period between 2024 and 2030.

Global CAR-T Cell Therapy Market – Industry Trends & Forecast Report, 2030

Global CAR-T Cell Therapy Market size by value was estimated at USD 9.11 billion in 2023. During the forecast period between 2024 and 2030, Global CAR-T Cell Therapy Market size is expected to expand at a CAGR of 30.20% reaching a value of USD 56.80 billion by 2030. The increasing prevalence of cancer necessitates innovative treatments, boosting demand for CAR-T therapies. Advancements in CAR-T technology enhance treatment efficacy and safety. A growing demand for targeted and personalized therapies further propels market growth. Additionally, rising clinical trial activities and supportive regulatory frameworks encourage research and development, fostering the expansion of Global CAR-T Cell Therapy Market during the period in analysis.

CAR-T Cell Therapy Market

CAR-T Cell Therapy – Overview

CAR-T cell therapy is an advanced treatment for certain types of leukemia. This includes the elimination of a patient’s T cells, genetic manipulation to express chimeric antigen receptors (CARs) that target cancer cells, and reintroduction into the patient. These modified T cells can effectively identify and destroy cancer cells. This shows promising results from generic medicine, especially where other treatments have failed.

Global CAR-T Cell Therapy Market

Growth Drivers

Increasing Prevalence of Cancer

Rising incidence of cancer across the globe is driving Global CAR-T Cell Therapy Market. As the incidence of cancer rises, so does the need for new and effective treatments. CAR-T cell therapy, with a targeted approach, offers promising results for patients with several cancers. This demand for advanced therapies drives research and development, leading to more clinical trials and regulatory approvals, and driving market growth.

Challenges

High Cost of CAR-T Cell Therapy

High cost of CAR-T cell therapy significantly restrains the market growth. These treatments, which range in price from USD 300,000 to USD 600,000, can exceed USD 100,000 when combined with clinical care and adverse reactions. The complicated process and extensive clinical trials contribute to this high cost. Consequently, the financial burden on patients and healthcare systems limits their uptake, posing a significant challenge to market expansion.

Impact of Escalating Geopolitical Tensions on Global CAR-T Cell Therapy Market

Intensifying and further spreading of geopolitical tensions among countries across the major regions could significantly impact Global CAR-T Cell Therapy Market. Supply chain constraints and trade constraints delay the availability of essential raw materials and inputs. The high cost of these products further complicates the production budget. Political instability can affect regulatory approval and clinical trial processes, leading to delays in bringing new therapies to market. Further, increased geopolitical risk can deter investment in research and development, slowing down innovation. All of these challenges impede market growth and access, making it difficult for patients to access advanced CAR T-cell therapy.

Global CAR-T Cell Therapy Market

Segmental Coverage

Global CAR-T Cell Therapy Market – By Indication

By indication, Global CAR-T Cell Therapy Market is divided into Acute Lymphoblastic Leukemia, Non-Hodgkin Lymphoma, and Multiple Myeloma segments. Non-Hodgkin Lymphoma (NHL) segment holds the largest market share of Global CAR-T Cell Therapy Market by indication. The dominance is due to the high prevalence of NHL and the effectiveness of CAR-T therapies in treating this type of cancer. The success of CAR-T cell therapies in clinical trials and their approval for treating relapsed or refractory NHL contribute to the segment's dominance.

CAR-T Cell Therapy Market Size

Global CAR-T Cell Therapy Market – By End User

Based on end user, Global CAR-T Cell Therapy Market is divided into Hospitals and Oncology Treatment Centers segments. The hospitals segment holds a larger market share of Global CAR-T Cell Therapy Market by end user, due to hospitals’ advanced infrastructure, availability of specialized medical professionals, and comprehensive care facilities. They are the primary centers for administering CAR-T cell therapies, managing complex cases, and providing necessary post-treatment care. This dominance is driven by the need for highly controlled environments to ensure patient safety and treatment efficacy.

CAR-T Cell Therapy Market Growth

Global CAR-T Cell Therapy Market – By Region

Geographically, Global CAR-T Cell Therapy Market is divided into North America, Europe, Asia Pacific (APAC), Latin America (LATAM), and Middle East and Africa (MEA). North America is the leading region of Global CAR-T Cell Therapy Market. This region holds the largest market share due to advanced healthcare infrastructure, high investment in research and development, and the presence of key market players. Additionally, the high prevalence of cancer and supportive regulatory frameworks further drive the adoption of CAR-T cell therapies in North America.

CAR-T Cell Therapy Market Share

Competitive Landscape

Key players in the highly competitive Global CAR-T Cell Therapy Market include Bristol-Myers Squibb, Sorrento Therapeutics, Inc., Celgene Corporation, Merck & Co., Inc., Novartis AG, Celyad Oncology, Juno Therapeutics, Inc., Autolus Therapeutics, Cellectis, Miltenyi Biotech, Intellia Therapeutics, and Pfizer, Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In October 2023 - ImmunoACT gained approval from the Central Drugs Standard Control Organization for its CAR-T cell therapy for treating relapsed/refractory B-cell lymphomas and leukemia in India.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2023

Base Year – 2023

Estimated Year – 2024

Forecast Period – 2024–2030

Facts Covered

Revenue in USD Billion 

Market Coverage

North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA)

Product/Service Segmentation

Drug Indication, Indication, End User, Region

Key Players

Bristol-Myers Squibb, Sorrento Therapeutics, Inc., Celgene Corporation, Merck & Co., Inc., Novartis AG, Celyad Oncology, Juno Therapeutics, Inc., Autolus Therapeutics, Cellectis, Miltenyi Biotech, Intellia Therapeutics, Pfizer, Inc.

 

By Drug Indication

  • Axicabtagene Ciloleucel (Yescarta)

  • Brexucabtagene Autoleucel (Tecartus)

  • Ciltacabtagene Autoleucel (Carvykti)

  • Idecabtagene Vicleucel (Abecma)

  • Lisocabtagene Maraleucel (Breyanzi)

  • Tisagenlecleucel (Kymriah)

  • Others

By Indication

  • Acute Lymphoblastic Leukemia

  • Non-Hodgkin Lymphoma

  • Multiple Myeloma

By End User

  • Hospitals

  • Oncology Treatment Centers

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America (LATAM)

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global CAR-T Cell Therapy Market Insights
    1. End User Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Rising prevalence of cancer
        2. Continuous advancements in cell engineering and genetic modification techniques
        3. Favorable regulatory landscape: for CAR-T cell therapy
        4. Growing interest from pharmaceutical companies, biotech firms, and investors
      2. Restraints
        1. High costs of CAR-T cell therapy
        2. Limited availability and access to CAR-T cell therapy is often restricted to a limited number of patients.
        3. Potential side effects associated with CAR-T cell therapy
      3. Opportunities
        1. Expansion into new indications
        2. Combining CAR-T cell therapy with other treatments
        3. Advancements in genomics and personalized medicine
      4. Challenges
        1. Manufacturing challenges associated with the production of CAR-T cell therapies
        2. Ensuring adequate reimbursement for CAR-T cell therapy
    3. Technological Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global CAR-T Cell Therapy Market: Marketing Strategies
  5. Global CAR-T Cell Therapy Market: Pricing Analysis
  6. Global CAR-T Cell Therapy Market: Geography Analysis
    1. Global CAR-T Cell Therapy Market, Geographical Analysis, 2023
    2. Global CAR-T Cell Therapy, Market Attractiveness Analysis, 2024–2030
  7. Global CAR-T Cell Therapy Market Overview
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Indication
        1. Axicabtagene Ciloleucel (Yescarta)
        2.  Brexucabtagene Autoleucel (Tecartus)
        3. Ciltacabtagene Autoleucel (Carvykti)
        4. Idecabtagene Vicleucel (Abecma)
        5. Lisocabtagene Maraleucel (Breyanzi)
        6. Tisagenlecleucel (Kymriah)
        7. Others
      2. By Indication
        1. Acute Lymphoblastic Leukemia
        2. Non-Hodgkin Lymphoma
        3.  Multiple Myeloma
      3. By End User
        1. Hospitals
        2. Oncology Treatment Centers
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  8. North America CAR-T Cell Therapy Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Indication
      2. By Indication
      3. By End User
      4. By Country
        1. United States
          1. By Drug Indication
          2. By Indication
          3. By End User
        2. Canada
          1. By Drug Indication
          2. By Indication
          3. By End User
  9. Europe CAR-T Cell Therapy Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Indication
      2. By Indication
      3. By End User
      4. By Country
        1. Germany
          1. By Drug Indication
          2. By Indication
          3. By End User
        2. United Kingdom
          1. By Drug Indication
          2. By Indication
          3. By End User
        3. Italy
          1. By Drug Indication
          2. By Indication
          3. By End User
        4. France
          1. By Drug Indication
          2. By Indication
          3. By End User
        5. Spain
          1. By Drug Indication
          2. By Indication
          3. By End User
        6. Belgium
          1. By Drug Indication
          2. By Indication
          3. By End User
        7. Russia
          1. By Drug Indication
          2. By Indication
          3. By End User
        8. The Netherlands
          1. By Drug Indication
          2. By Indication
          3. By End User
        9. Rest of Europe
          1. By Drug Indication 
          2. By Indication
          3. By End User
  10. Asia Pacific CAR-T Cell Therapy Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Indication
      2. By Indication
      3. By End User
      4. By Country
        1. China
          1. By Drug Indication
          2. By Indication
          3. By End User
        2. India
          1. By Drug Indication
          2. By Indication
          3. By End User
        3. Japan
          1. By Drug Indication
          2. By Indication
          3. By End User
        4. South Korea
          1. By Drug Indication
          2. By Indication
          3. By End User
        5. Australia & New Zealand
          1. By Drug Indication
          2. By Indication
          3. By End User
        6. Indonesia
          1. By Drug Indication
          2. By Indication
          3. By End User
        7. Malaysia
          1. By Drug Indication
          2. By Indication
          3. By End User
        8. Singapore
          1. By Drug Indication
          2. By Indication
          3. By End User
        9. Vietnam
          1. By Drug Indication
          2. By Indication
          3. By End User
        10. Rest of APAC
          1. By Drug Indication
          2. By Indication
          3. By End User
  11. Latin America CAR-T Cell Therapy Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Indication
      2. By Indication
      3. By End User
      4. By Country
        1. Brazil
          1. By Drug Indication
          2. By Indication
          3. By End User
        2. Mexico
          1. By Drug Indication
          2. By Indication
          3. By End User
        3. Argentina
          1. By Drug Indication
          2. By Indication
          3. By End User
        4. Peru
          1. By Drug Indication
          2. By Indication
          3. By End User
        5. Rest of LATAM
          1. By Drug Indication
          2. By Indication
          3. By End User
  12. Middle East and Africa CAR-T Cell Therapy Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Indication
      2. By Indication
      3. By End User
      4. By Country
        1. Saudi Arabia
          1. By Drug Indication
          2. By Indication
          3. By End User
        2. UAE
          1. By Drug Indication
          2. By Indication
          3. By End User
        3. Qatar
          1. By Drug Indication
          2. By Indication
          3. By End User
        4. Kuwait
          1. By Drug Indication
          2. By Indication
          3. By End User
        5. South Africa
          1. By Drug Indication
          2. By Indication
          3. By End User
        6. Nigeria
          1. By Drug Indication
          2. By Indication
          3. By End User
        7. Algeria
          1. By Drug Indication
          2. By Indication
          3. By End User
        8. Rest of MEA
          1. By Drug Indication
          2. By Indication
          3. By End User
  13. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global CAR-T Cell Therapy Company Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  14. Impact of Escalating Geopolitical Tensions on Global CAR-T Cell Therapy Market
  15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Bristol-Myers Squibb
    2. Sorrento Therapeutics, Inc.
    3. Celgene Corporation
    4. Merck & Co., Inc.
    5. Novartis AG
    6. Celyad Oncology
    7. Juno Therapeutics, Inc.
    8. Autolus Therapeutics
    9. Cellectis
    10. Miltenyi Biotech
    11. Intellia Therapeutics
    12. Pfizer, Inc.
    13. Other Prominent Players
  16. Key Strategic Recommendations
  17. Research Methodology
    1.       Qualitative Research
      1.   Primary & Secondary Research
    2.       Quantitative Research
    3.       Market Breakdown & Data Triangulation
      1.   Secondary Research
      2.   Primary Research
    4.       Breakdown of Primary Research Respondents, By Region
    5.       Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

 

List of Figures

 

Figure 1       Global CAR-T Cell Therapy Segmentation

Figure 2       Global CAR-T Cell Therapy Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2023

Figure 4       Global CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 5       Global CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 6       Global CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 7       Global CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 8       Global CAR-T Cell Therapy Market Share, By Region, By Value (USD Billion), 2019–2030

Figure 9       North America CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 10     North America CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 11     North America CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 12     North America CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 13     North America CAR-T Cell Therapy Market Share, By Country, By Value (USD Billion), 2019–2030

Figure 14     United States CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 15     United States CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 16     United States CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 17     United States CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 18     Canada CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 19     Canada CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 20     Canada CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 21     Canada CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 22     Europe CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 23     Europe CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 24     Europe CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 25     Europe CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 26     Europe CAR-T Cell Therapy Market Share, By Country, By Value (USD Billion), 2019–2030

Figure 27     Germany CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 28     Germany CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 29     Germany CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 30     Germany CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 31     United Kingdom CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 32     United Kingdom CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 33     United Kingdom CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 34     United Kingdom CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 35     Italy CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 36     Italy CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 37     Italy CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 38     Italy CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 39     France CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 40     France CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 41     France CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 42     France CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 43     Spain CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 44     Spain CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 45     Spain CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 46     Spain CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 47     Belgium CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 48     Belgium CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 49     Belgium CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 50     Belgium CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 51     Russia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 52     Russia CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 53     Russia CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 54     Russia CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 55     The Netherlands CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 56     The Netherlands CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 57     The Netherlands CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 58     The Netherlands CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 59     Rest of Europe CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 60     Rest of Europe CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 61     Rest of Europe CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 62     Rest of Europe CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 63     Asia Pacific CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 64     Asia Pacific CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 65     Asia Pacific CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 66     Asia Pacific CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 67     Asia Pacific CAR-T Cell Therapy Market Share, By Country, By Value (USD Billion), 2019–2030

Figure 68     China CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 69     China CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 70     China CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 71     China CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 72     India CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 73     India CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 74     India CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 75     India CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 76     Japan CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 77     Japan CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 78     Japan CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 79     Japan CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 80     South Korea CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 81     South Korea CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 82     South Korea CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 83     South Korea CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 84     Australia & New Zealand CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 85     Australia & New Zealand CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 86     Australia & New Zealand CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 87     Australia & New Zealand CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 88     Indonesia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 89     Indonesia CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 90     Indonesia CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 91     Indonesia CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 92     Malaysia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 93     Malaysia CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 94     Malaysia CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 95     Malaysia CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 96     Singapore CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 97     Singapore CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 98     Singapore CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 99     Singapore CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 100   Vietnam CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 101   Vietnam CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 102   Vietnam CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 103   Vietnam CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 104   Rest of APAC CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 105   Rest of APAC CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 106   Rest of APAC CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 107   Rest of APAC CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 108   Latin America CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 109   Latin America CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 110   Latin America CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 111   Latin America CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 112   Latin America CAR-T Cell Therapy Market Share, By Country, By Value (USD Billion), 2019–2030

Figure 113   Brazil CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 114   Brazil CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 115   Brazil CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 116   Brazil CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 117   Mexico CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 118   Mexico CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 119   Mexico CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 120   Mexico CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 121   Argentina CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 122   Argentina CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 123   Argentina CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 124   Argentina CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 125   Peru CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 126   Peru CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 127   Peru CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 128   Peru CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 129   Rest of LATAM CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 130   Rest of LATAM CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 131   Rest of LATAM CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 132   Rest of LATAM CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 133   Middle East and Africa CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 134   Middle East and Africa CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 135   Middle East and Africa CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 136   Middle East and Africa CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 137   Middle East and Africa CAR-T Cell Therapy Market Share, By Country, By Value (USD Billion), 2019–2030

Figure 138   Saudi Arabia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 139   Saudi Arabia CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 140   Saudi Arabia CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 141   Saudi Arabia CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 142   UAE CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 143   UAE CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 144   UAE CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 145   UAE CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 146   Qatar CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 147   Qatar CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 148   Qatar CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 149   Qatar CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 150   Kuwait CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 151   Kuwait CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 152   Kuwait CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 153   Kuwait CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 154   South Africa CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 155   South Africa CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 156   South Africa CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 157   South Africa CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 158   Nigeria CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 159   Nigeria CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 160   Nigeria CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 161   Nigeria CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 162   Algeria CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 163   Algeria CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 164   Algeria CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 165   Algeria CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 166   Rest of MEA CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 167   Rest of MEA CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 168   Rest of MEA CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 169   Rest of MEA CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

 

List of Tables

 

Table 1        Global CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030  

Table 2        Global CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 3        Global CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 4        Global CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 5        Global CAR-T Cell Therapy Market Size, By Region, By Value (USD Billion), 2019–2030 

Table 6        North America CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 7        North America CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 8        North America CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030        

Table 9        North America CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 10      North America CAR-T Cell Therapy Market Size, By Country, By Value (USD Billion), 2019–2030 

Table 11      United States CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 12      United States CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 13      United States CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030        

Table 14      United States CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 15      Canada CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030 

Table 16      Canada CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 17      Canada CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 18      Canada CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 19      Europe CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030 

Table 20      Europe CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 21      Europe CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 22      Europe CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 23      Europe CAR-T Cell Therapy Market Size, By Country, By Value (USD Billion), 2019–2030 

Table 24      Germany CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 25      Germany CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 26      Germany CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 27      Germany CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 28      United Kingdom CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030 

Table 29      United Kingdom CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 30      United Kingdom CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030        

Table 31      United Kingdom CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030        

Table 32      Italy CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030     

Table 33      Italy CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 34      Italy CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 35      Italy CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 36      France CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030  

Table 37      France CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 38      France CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 39      France CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 40      Spain CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030   

Table 41      Spain CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 42      Spain CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 43      Spain CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 44      Belgium CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 45      Belgium CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 46      Belgium CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 47      Belgium CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 48      Russia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030  

Table 49      Russia CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 50      Russia CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 51      Russia CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 52      The Netherlands CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030 

Table 53      The Netherlands CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 54      The Netherlands CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030        

Table 55      The Netherlands CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030        

Table 56      Rest of Europe CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 57      Rest of Europe CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 58      Rest of Europe CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030        

Table 59      Rest of Europe CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 60      Asia Pacific CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 61      Asia Pacific CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 62      Asia Pacific CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 63      Asia Pacific CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 64      Asia Pacific CAR-T Cell Therapy Market Size, By Country, By Value (USD Billion), 2019–2030 

Table 65      China CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030   

Table 66      China CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 67      China CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 68      China CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 69      India CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030    

Table 70      India CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 71      India CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 72      India CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 73      Japan CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030   

Table 74      Japan CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 75      Japan CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 76      Japan CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 77      South Korea CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 78      South Korea CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 79      South Korea CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 80      South Korea CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 81      Australia & New Zealand CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030 

Table 82      Australia & New Zealand CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 83      Australia & New Zealand CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 84      Australia & New Zealand CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 85      Indonesia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 86      Indonesia CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 87      Indonesia CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 88      Indonesia CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 89      Malaysia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 90      Malaysia CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 91      Malaysia CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 92      Malaysia CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 93      Singapore CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 94      Singapore CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 95      Singapore CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 96      Singapore CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 97      Vietnam CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 98      Vietnam CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 99      Vietnam CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 100    Vietnam CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 101    Rest of APAC CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 102    Rest of APAC CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 103    Rest of APAC CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 104    Rest of APAC CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 105    Latin America CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 106    Latin America CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 107    Latin America CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030        

Table 108    Latin America CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 109    Latin America CAR-T Cell Therapy Market Size, By Country, By Value (USD Billion), 2019–2030 

Table 110    Brazil CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030    

Table 111    Brazil CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 112    Brazil CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 113    Brazil CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 114    Mexico CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030  

Table 115    Mexico CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 116    Mexico CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 117    Mexico CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 118    Argentina CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 119    Argentina CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 120    Argentina CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 121    Argentina CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 122    Peru CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030     

Table 123    Peru CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 124    Peru CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 125    Peru CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 126    Rest of LATAM CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 127    Rest of LATAM CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 128    Rest of LATAM CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030        

Table 129    Rest of LATAM CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 130    Middle East and Africa CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030 

Table 131    Middle East and Africa CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 132    Middle East and Africa CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 133    Middle East and Africa CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030        

Table 134    Middle East and Africa CAR-T Cell Therapy Market Size, By Country, By Value (USD Billion), 2019–2030        

Table 135    Saudi Arabia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 136    Saudi Arabia CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 137    Saudi Arabia CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 138    Saudi Arabia CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 139    UAE CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030      

Table 140    UAE CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 141    UAE CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 142    UAE CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 143    Qatar CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030   

Table 144    Qatar CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 145    Qatar CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 146    Qatar CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 147    Kuwait CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030  

Table 148    Kuwait CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 149    Kuwait CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 150    Kuwait CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 151    South Africa CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 152    South Africa CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 153    South Africa CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 154    South Africa CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 155    Nigeria CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030 

Table 156    Nigeria CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 157    Nigeria CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 158    Nigeria CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 159    Algeria CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030  

Table 160    Algeria CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030 

Table 161    Algeria CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 162    Algeria CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 163    Rest of MEA CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 164    Rest of MEA CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030        

Table 165    Rest of MEA CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030 

Table 166    Rest of MEA CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030 

Table 167    Bristol-Myers Squibb Company Overview

Table 168    Bristol-Myers Squibb Financial Overview

Table 169    Sorrento Therapeutics, Inc. Company Overview

Table 170    Sorrento Therapeutics, Inc. Financial Overview

Table 171    Celgene Corporation Company Overview

Table 172    Celgene Corporation Financial Overview

Table 173    Merck & Co., Inc. Company Overview

Table 174    Merck & Co., Inc. Financial Overview

Table 175    Novartis AG Company Overview

Table 176    Novartis AG Financial Overview

Table 177    Celyad Oncology Company Overview

Table 178    Celyad Oncology Financial Overview

Table 179    Juno Therapeutics, Inc. Company Overview

Table 180    Juno Therapeutics, Inc. Financial Overview

Table 181    Autolus Therapeutics Company Overview

Table 182    Autolus Therapeutics Financial Overview

Table 183    Cellectis Company Overview

Table 184    Cellectis Financial Overview

Table 185    Miltenyi Biotech Company Overview

Table 186    Miltenyi Biotech Financial Overview

Table 187    Intellia Therapeutics Company Overview

Table 188    Intellia Therapeutics Financial Overview

Table 189    Pfizer, Inc. Company Overview

Table 190    Pfizer, Inc. Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Global CAR-T Cell Therapy Market size by value was estimated at USD 9.11 billion in 2023.
Ans: Global CAR-T Cell Therapy Market by value is expected to grow at a CAGR of 30.20% during the forecast period between 2024 and 2030.
Ans: Global CAR-T Cell Therapy Market size is forecast to reach a value of USD 56.80 billion by 2030.
Ans: The growth of Global CAR-T Cell Therapy Market is primarily driven by growing incidence of cancer, demand for targeted and personalized therapies, advances in CAR-T technology, and increasing clinical trial activities.
Ans: North America is the leading region of Global CAR-T Cell Therapy Market.
Ans: Key players in Global CAR-T Cell Therapy Market include Bristol-Myers Squibb, Sorrento Therapeutics, Inc., Celgene Corporation, Merck & Co., Inc., Novartis AG, Celyad Oncology, Juno Therapeutics, Inc., Autolus Therapeutics, Cellectis, Miltenyi Biotech, Intellia Therapeutics, and Pfizer, Inc.